Most factors impacting health and life expectancy occur outside of the clinical setting. By engaging the Veteran in a holistic manner, the VA can deliver personalized care options. Salesforce explains how a Veteran-centric digital experience improves engagement and care plan adherence, resulting in better outcomes.
Colonel Horvath is Board Certified in internal medicine and preventive medicine for 40 years. In this interview, he shares his opinion on the most pertinent health hazards facing combat and non-combat deployed troops today.
In this snapshot you will find the titles and agencies of the men and women who lead the effort to care for our veterans on a daily basis and who signed up to be in attendance at the last event. Will you be there to meet them this year?
In this exclusive interview with Combat & Casualty, MG Richard Thomas Commander (Outgoing) Western Regional Medical Command, Director (Incoming) Health Care Operations, Defense Health Agency talks about the primary advances to address the needs of combat casualties. In addition, MG Thomas discusses the challenges regarding lessons learned on today’s asymmetric battlefields
You may know that the Department of Veteran’s Affairs estimates a veteran takes his or her own life about once every sixty-five minutes on average. This alarming statistic highlights the stark reality of post-deployment healthcare, especially in rural areas. In the following IDGA exclusive interview, Alice Franks, speaks about the importance of rural based strategies, including community response teams, and her role as Co-Founder of the ‘National Alliance to End Veteran Suicides’.
IDGA's largest healthcare program, VA Healthcare Summit, has captured the attention of the industry. More then 100 professionals of the Veterans Integrated Service Networks attended. This map details the regions the attendees represented.
This article by CDR James V. Lawler, Deputy Director, JC2RT states the outcomes and improvements made by evidence based medicine (EBM). In addition, it will show you the importance on why clinical trials are essential for the continues development of combat casualty care
Dr. William Patterson, Network Director, VISN 15 discusses:
- Identifying areas of improvement and creating effective policy measures to combat them
- Establishing a culture of continuous improvement and transitioning the VA into a high performing organization
- Implementing a shared vision across a region
Thomas Lynch, MD, Assistant Deputy USH for Clinical Operations and Management discusses:
- Ensuring the delivery of exceptional care to the Veteran population
- Streamlining operations to minimize preventable mistakes
Robert B. Belshe, MD, Dianna and J. Joseph Adorjan Endowed Professor of Infectious Diseases and Immunology, Saint Louis University School of Medicine discusses:
- The Impact of Influenza Disease in Seniors
- The Impact of Influenza Vaccine in the Senior Population
- Responding to a Need: Fluzone High-Dose (Influenza Vaccine)
- The Post-Licensure Efficacy Study
- Product Information and Summary of Key Points
One of the challenges of Veteran healthcare is the smooth transition of men and women from the DoD to VA health services. According to Dr Carie Rodgers, Associate Director, VA Center of Excellence, “we are working very hard to make sure returning military members know about VA services and know how to access those services”. This IDGA exclusive examines the latest updates and advancement being explored for the future of healthcare for Veterans, including the ability to reach Veterans in rural areas of the United States.
The dire need for improvement in the business processes within The Department of Veteran’s Affairs (VA) has been a source of much discussion over the past few months. With the appointment of David Shulkin as the Secretary of Veterans Affairs in February has come renewed hope and need for greater accountability. In his May 31st State of VA report, Shulkin detailed 13 areas within which the department will be working towards improvements.
IV catheter placement remains the most common invasive hospital procedure performed worldwide. This whitepaper summarizes the clinical research that established the operational capabilities of the ivWatch device, and formed the basis of the data submitted to the FDA in support of the ivWatch 510(k) Premarket Notification.